Regina Galera
Director, Regulatory and Clinical Consulting, Life Sciences and Healthcare
Regina is a MSc Industrial Pharmacist by the University of Barcelona with over 19 years of experience in the Pharmaceutical and Medical Device Industry. She is a seasoned professional within the Regulatory, Clinical, Quality and Vigilance fields across EMEA, North America, Latin America, Asia Pacific and Japanese markets.
She has experience both in Industry with international companies such as Alcon (Novartis), Smith & Nephew and Olympus as well as in Consulting (IQVIA) interacting with Competent Authorities, Notified Bodies, Certification Bodies and Third-party auditors. Among others, she has worked with ophthalmic drugs, antibiotics, anesthetics, aesthetic products, combination products, class I-III medical devices, including implantable, custom-made, active and software as a medical device (SaMD).
She leads a team of experienced consultants who are focused on developing strategic technology enabled customized Regulatory and Clinical solutions with a holistic approach for Pharmaceuticals, Biologics, Medical Devices, Combination products and Consumer Health covering more than 140 countries.
Latest news
Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions London, U.K. November 24, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider…
Clarivate RiskMark Wins 2025 LegalTech Breakthrough Award For “LegalTech Predictive AI Solution of the Year”
Annual awards program recognizes companies and products driving innovation in the global legal technology industry AI-powered RiskMark delivers near-instant, data-backed insights London, U.K. November 13, 2025. Clarivate Plc (NYSE:CLVT), a…
